Equetro Capsule, Extended Release
Pricing Report NDC 30698-421-12

Current NADAC: $4.16981 per EA · Effective Aug 19, 2026 · Est. package price $500.38 (120 EA)

Current Package Pricing Information

The current wholesale acquisition cost for Equetro (NDC 30698-421-12) is $4.16981 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 19, 2026.

As a a human prescription drug provided by Validus Pharmaceuticals Llc, this medication is distributed in a 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$4.16981
Per EA

Effective Date
Aug 19, 2026
Billable Units
120 EA
Estimated Package Price
$500.38
Data Status
As of Sep 09, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jul 2013, the NADAC wholesale price for (NDC ) has moved within a range of $2.10269 to $4.18410 per EA. Over this 13 years and 1 month period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$2.1027 - $4.1841
Market Volatility
98.99% Variance
Latest Trend
0.05%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 19, 2026 $4.16981 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 22, 2026 $4.16769 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jun 17, 2026 $4.16769 EAC/I - Chain or Independent PharmacyCode 1B - Brand
May 20, 2026 $4.18293 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Apr 22, 2026 $4.16304 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Mar 18, 2026 $4.15734 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Feb 18, 2026 $4.15880 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jan 21, 2026 $4.16795 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Dec 17, 2025 $4.16119 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Nov 19, 2025 $4.16195 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Oct 22, 2025 $4.16367 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Sep 17, 2025 $4.16523 EAC/I - Chain or Independent PharmacyCode 1B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026